Keeping Current

521 Epizód

1. Treating MS Early: Who, How, and When?

   Közzétéve: 2021. 06. 14.
2. Bispecific Antibodies: The Case for Non-BCMA Targets

   Közzétéve: 2021. 06. 11.
3. Tackling Adherence in Dyslipidemia: Concrete Actions for Better Outcomes

   Közzétéve: 2021. 06. 04.
4. SARS-CoV-2 Vaccine Candidates: Expertise and Updates

   Közzétéve: 2021. 06. 04.
5. Practical Strategies to Overcome Poor Vaccine Uptake During the COVID-19 Pandemic

   Közzétéve: 2021. 06. 04.
6. COVID-19: The Path to Immunity

   Közzétéve: 2021. 06. 03.
7. Optimal Implementation of the COVID-19 Vaccine: Best Practice and Strategies for Success

   Közzétéve: 2021. 06. 02.
8. Beyond Clinical Trials: Treating nAMD in Clinical Practice

   Közzétéve: 2021. 05. 27.
9. Molecularly Guided Therapy in Oncology Practice: The Evolving State of the Art

   Közzétéve: 2021. 05. 25.
10. ENDO 2021 – New Directions With Weight Loss Concepts of the Future

    Közzétéve: 2021. 05. 25.
11. Taking Control of Chronic Spontaneous Urticaria: A Tale of Two Perspectives

    Közzétéve: 2021. 05. 19.
12. Advances in Oncogene-Driven Metastatic NSCLC: Focusing on EFGR Exon 20 Insertions and ALK-Positive NSCLC

    Közzétéve: 2021. 05. 11.
13. HFpEF Is Arguably the Greatest Unmet Need in Cardiology: The Potential Role of SGLT2 Inhibitors

    Közzétéve: 2021. 05. 06.
14. Patient Engagement in MS: What Does This Mean and What Does It Look Like?

    Közzétéve: 2021. 05. 05.
15. Neuro-Ophthalmology: What You Need to Know About LHON

    Közzétéve: 2021. 04. 30.
16. The Science of MS and Role of S1P Receptor Modulators

    Közzétéve: 2021. 04. 30.
17. Emerging Therapies for Chronic Spontaneous Urticaria: Understanding How They Work

    Közzétéve: 2021. 04. 21.
18. Molecular Testing – Transplant and Treatment Strategies in AML

    Közzétéve: 2021. 04. 21.
19. New Approaches to Ocular Surface Pain

    Közzétéve: 2021. 04. 19.
20. Defining NASH As a Metabolic Disease: Can We Afford to Ignore It?

    Közzétéve: 2021. 04. 19.